(E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methylstyryl)-1,3,3-trimethyl-3H-indol-1-ium chloride

Catalog No. :
ACIVBG156
CAS No. :
6441-82-3
Molecular Formula :
C24H30Cl2N2
Molecular Weight :
417.42

IUPAC Name:(E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methylstyryl)-1,3,3-trimethyl-3H-indol-1-ium chloride

(E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methylstyryl)-1,3,3-trimethyl-3H-indol-1-ium chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$98.00Login to see priceInquiryInquiry
25g98%$233.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methylstyryl)-1,3,3-trimethyl-3H-indol-1-ium chloride
IUPAC Name(E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methylstyryl)-1,3,3-trimethyl-3H-indol-1-ium chloride
Molecular FormulaC24H30Cl2N2
Molecular Weight417.42
SMILESCCN(CCCl)C1=CC=C(/C=C/C2=[N+](C)C3=C(C=CC=C3)C2(C)C)C(C)=C1.[Cl-]
InChI KeyJQZWHMOVSQRYRN-UHFFFAOYSA-M
SynonymMFCD00059990 | Red Astrazone 66 | Genacryl Red 6B | BS-23474 | Aizen Cathilon Red 6B | Basic violet 7 | C.I. 48020 | Nabor Brilliant Red 6B | Aizen Cathilon Red 6BH | NSC4433 | NSC-4433 | Sumiacryl Red 6B | (E)-2-(4-((2-chloroethyl)(ethyl)amino)-2-methyls
CAS No.6441-82-3
PubChem CID6538422

Synthetic Route by SureRoute

1. ACIVBG156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVBG156 route product structure diagram
    ACIVBG1566441-82-3
Inquiry

2. ACIVBG156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVBG156 route product structure diagram
    ACIVBG1566441-82-3
Inquiry

Comments (0)